Arkolith/Insider Trading/MACK/Form 4

Crocker Gary L

See Remarks, DirectorMERRIMACK PHARMACEUTICALS INC (MACK) · full profile →Form 4 · filed Aug 14, 2023
Net Buying
Open-Market Buys
$50K
Open-Market Sells
$0
Net Open-Market Flow
$50K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 11, 2023Buy(P)2K$12.43$25K133K
Aug 10, 2023Buy(P)2K$12.52$25K133K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-23-042384) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML